1. Home
  2. TRVI vs AMAL Comparison

TRVI vs AMAL Comparison

Compare TRVI & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • AMAL
  • Stock Information
  • Founded
  • TRVI 2011
  • AMAL 1923
  • Country
  • TRVI United States
  • AMAL United States
  • Employees
  • TRVI N/A
  • AMAL N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • AMAL Commercial Banks
  • Sector
  • TRVI Health Care
  • AMAL Finance
  • Exchange
  • TRVI Nasdaq
  • AMAL Nasdaq
  • Market Cap
  • TRVI 725.7M
  • AMAL 858.7M
  • IPO Year
  • TRVI 2019
  • AMAL 2018
  • Fundamental
  • Price
  • TRVI $8.07
  • AMAL $28.19
  • Analyst Decision
  • TRVI Strong Buy
  • AMAL Hold
  • Analyst Count
  • TRVI 9
  • AMAL 2
  • Target Price
  • TRVI $20.72
  • AMAL $33.00
  • AVG Volume (30 Days)
  • TRVI 2.9M
  • AMAL 147.6K
  • Earning Date
  • TRVI 11-05-2025
  • AMAL 10-23-2025
  • Dividend Yield
  • TRVI N/A
  • AMAL 1.99%
  • EPS Growth
  • TRVI N/A
  • AMAL 3.73
  • EPS
  • TRVI N/A
  • AMAL 3.34
  • Revenue
  • TRVI N/A
  • AMAL $304,724,000.00
  • Revenue This Year
  • TRVI N/A
  • AMAL $9.82
  • Revenue Next Year
  • TRVI N/A
  • AMAL $11.11
  • P/E Ratio
  • TRVI N/A
  • AMAL $8.42
  • Revenue Growth
  • TRVI N/A
  • AMAL 4.35
  • 52 Week Low
  • TRVI $2.36
  • AMAL $25.03
  • 52 Week High
  • TRVI $9.92
  • AMAL $38.19
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 53.13
  • AMAL 41.18
  • Support Level
  • TRVI $6.93
  • AMAL $28.32
  • Resistance Level
  • TRVI $9.92
  • AMAL $29.19
  • Average True Range (ATR)
  • TRVI 0.76
  • AMAL 0.60
  • MACD
  • TRVI 0.11
  • AMAL -0.00
  • Stochastic Oscillator
  • TRVI 37.96
  • AMAL 5.49

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About AMAL Amalgamated Financial Corp. (DE)

Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.

Share on Social Networks: